- Generic name
- Linagliptin + Metformin Hydrochloride
- Strength
- 2.5 mg + 850 mg
- Dosage form
- Tablet
- Manufactured by
- Opsonin Pharma Limited
Linadus M 2.5/850 mg Tablet
About Linadus M 2.5/850 mg Tablet
The tablet Linadus M 2.5/850 mg contains Linagliptin + Metformin Hydrochloride and is made by Opsonin Pharma Limited. It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person.
There are 31 brands of Linagliptin + Metformin Hydrochloride listed in Bangladesh. The lowest listed price is Linatin M 2.5 mg + 500 mg Tablet at ৳ 7.00 per unit.
What is Linadus M 2.5/850 mg Tablet?
Linadus M 2.5/850 mg 2.5 mg + 850 mg tablet is a medicine made by Opsonin Pharma Limited. Only a registered doctor can decide whether it suits a particular person, and the dose and course are set by the doctor. It belongs to a group of combination oral medicines used to lower blood sugar. Whether it suits you is a decision for your doctor.
Uses of Linadus M 2.5/850 mg
It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person. It is not meant to replace meal planning or physical activity. It is added to a proper diet and exercise plan to improve blood sugar control when treatment with both linagliptin and metformin is considered appropriate. Your doctor will decide if it is suitable for you.
How to use Linadus M 2.5/850 mg
Take Linadus M 2.5/850 mg exactly as your doctor tells you. Swallow the tablet with water. Linadus M 2.5/850 mg is taken by mouth. If you miss a dose, ask your doctor or pharmacist what to do. Do not change the amount or stop the medicine on your own.
Side effects of Linadus M 2.5/850 mg
Your doctor can advise on what to watch for. Low blood sugar (hypoglycemia) is more common when it is taken with sulfonylureas. Common side effects include nasopharyngitis (cold-like symptoms) and diarrhoea. Ask your doctor or pharmacist about anything you are unsure of. Tell your doctor if you notice any side effect that bothers you or does not go away, and seek medical help for anything severe.
Safety and precautions
Metformin is excreted by the kidneys, so the risk of accumulation and lactic acidosis rises as kidney function falls. It should be used in pregnancy only if clearly needed, and caution is advised during breastfeeding. Linadus M 2.5/850 mg is not suitable for people with kidney problems, as metformin can build up and raise the risk of lactic acidosis. Tell your doctor if you have kidney, liver, or heart problems, or if you are scheduled for surgery or a scan with contrast dye.
Frequently asked questions
What is Linadus M 2.5/850 mg used for?
It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person. It is not meant to replace meal planning or physical activity.
How is Linadus M 2.5/850 mg used?
Take Linadus M 2.5/850 mg exactly as your doctor tells you. Swallow the tablet with water.
Can Linadus M 2.5/850 mg cause side effects?
Your doctor can advise on what to watch for. Low blood sugar (hypoglycemia) is more common when it is taken with sulfonylureas.
Is Linadus M 2.5/850 mg safe for everyone?
Metformin is excreted by the kidneys, so the risk of accumulation and lactic acidosis rises as kidney function falls. It should be used in pregnancy only if clearly needed, and caution is advised during breastfeeding.
Indications
Pharmacology
Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.
Dosage & Administration
Recommended starting dose: In patients currently not treated with Metformin Hydrochloride, initiate treatment with 2.5 mg Linagliptin and 500 mg Metformin Hydrochloride twice daily.
In patients already treated with Metformin Hydrochloride, start with 2.5 mg Linagliptin and the current dose of Metformin Hydrochloride twice daily.
Patients already treated with Linagliptin and Metformin Hydrochloride, individual components may be switched to this combination containing the same doses of each component.
Linagliptin & Metformin extend release tablet: The dosage of this combination should be individualized on the basis of both effectiveness and tolerability, while not exceeding the maximum recommended total daily dose of Linagliptin 5 mg and Metformin Hydrochloride 2000 mg. this combination should be given once daily with a meal.
Recommended starting dose: In patients currently not treated with metformin, initiate this combination treatment with 5 mg Linagliptin/1000 mg Metformin Hydrochloride extended-release once daily with a meal.
In patients already treated with Metformin, start this combination with 5 mg of Linagliptin total daily dose and a similar total daily dose of Metformin once daily with a meal.
In patients already treated with Linagliptin & Metformin immediate release tablet, switch to extend release tablet containing 5 mg of Linagliptin total daily dose and a similar total daily dose of Metformin once daily with a meal.
5 mg Linagliptin & 1000 mg Metformin Hydrochloride extended-release tablet should be taken as a single tablet once daily. Patients using 2.5 mg Linagliptin & 1000 mg Metformin extended release tablets should take two tablets together once daily.
Interaction
P-glycoprotien/CYP3A4 inducer (i.e. rifampin): The efficacy of this medicine may be reduced when administered in combination.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
During controlled clinical trials in healthy subjects, with single doses of up to 600 mg of Linagliptin (equivalent to 120 times the recommended daily dose), there were no dose-related clinical adverse drug reactions.
Overdose of Metformin Hydrochloride has occurred in case of ingestion of amounts greater than 50 grams. Hypoglycemia was reported in approximately 10% of cases, but no causal association with Metformin Hydrochloride has been established. Lactic acidosis has been reported in approximately 32% of Metformin Hydrochloride overdose cases.
Storage Conditions
Alternative brands of Linagliptin + Metformin Hydrochloride
Other brands with the same generic name, cheapest first.
Linatin M Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Delta Pharma Limited
৳ 6.86 ৳ 7.00 2% off per unit
Linatin M Tablet
2.5 mg + 850 mg
Linagliptin + Metformin Hydrochloride
Delta Pharma Limited
৳ 7.84 ৳ 8.00 2% off per unit
Adlinameg Tablet
2.5 mg+500 mg
Linagliptin + Metformin Hydrochloride
UniMed UniHealth
৳ 11.76 ৳ 12.00 2% off per unit
Formet-L Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Biopharma Ltd.
৳ 11.76 ৳ 12.00 2% off per unit
Carlina-M Tablet
2.5 mg+500 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 12.74 ৳ 13.00 2% off per unit
Biolina Plus Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
Biogen Pharmaceuticals Ltd.
৳ 13.23 ৳ 13.5 2% off per unit
Adlinameg Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
UniMed UniHealth
৳ 13.72 ৳ 14.00 2% off per unit
Carlina-M Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 13.72 ৳ 14.00 2% off per unit
Carlina-M Tablet
2.5 mg+1000 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 15.68 ৳ 16.00 2% off per unit
Carlina-M 2.5/1000 Tablet
2.5 mg + 1000 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 15.68 ৳ 16 2% off per unit
Carlina-M 2.5/850 Tablet
2.5 mg + 850 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
Price not listed
Carlina-M FC Tablet Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
Price not listed
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.